SCIENTIFIC COMMITTEE
The Scientific Committee is responsible for reviewing proposals for research and related activities according to guidelines developed by the Board and making recommendations to the Board, and presenting the Board with annual reports and plans concerning the Society’s research activities. This Committee also reviews the applications submitted through the Histiocytosis Association's annual research funding program. The current members are:
Caroline Hutter - Chair
Children's Cancer Research Institute - Vienna, Austria
Term of Office: 2023 - 2025
Scott Canna
Children's Hospital of Philadelphia - Philadelphia, PA USA
Term of Office: 2022 - 2024
Benjamin Durham
Memorial Sloan Kettering Cancer Center - New York, NY USA
Term of Office: 2023 - 2025
Jean-Francois Emile
Versailles University, Paris-Saclay University - Paris, France
Term of Office: 2023 - 2025
Ronald Go
Mayo Clinic - Rochester, MN USA
Term of Office: 2023 - 2025
Sebastien Heritier
Asistance Publique - Hopitaux de Paris - Paris, France
Term of Office: 2023 - 2025
Michelle Hermiston
University of California, San Francisco - San Francisco, CA USA
Term of Office: 2023 - 2025
Ko Kudo
Hirosaki University Hospital - Hirosaki, Japan
Term of Office: 2022 - 2024
Paul Milne
Newcastle University - Newcastle, United Kingdom
Term of Office: 2022 - 2024
Astrid van Halteren
Erasmus Medical Center – Rotterdam, Netherlands
Term of Office: 2022 - 2024